Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

A novel molecular signature for elevated tricuspid regurgitation velocity in sickle cell disease.

Desai AA, Zhou T, Ahmad H, Zhang W, Mu W, Trevino S, Wade MS, Raghavachari N, Kato GJ, Peters-Lawrence MH, Thiruvoipati T, Turner K, Artz N, Huang Y, Patel AR, Yuan JX, Gordeuk VR, Lang RM, Garcia JG, Machado RF.

Am J Respir Crit Care Med. 2012 Aug 15;186(4):359-68. doi: 10.1164/rccm.201201-0057OC. Epub 2012 Jun 7.

2.

Pulmonary hypertension in sickle cell disease children under 10 years of age.

Colombatti R, Maschietto N, Varotto E, Grison A, Grazzina N, Meneghello L, Teso S, Carli M, Milanesi O, Sainati L.

Br J Haematol. 2010 Sep;150(5):601-9. doi: 10.1111/j.1365-2141.2010.08269.x. Epub 2010 Jun 10. Review.

PMID:
20553267
3.

Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease.

Niss O, Quinn CT, Lane A, Daily J, Khoury PR, Bakeer N, Kimball TR, Towbin JA, Malik P, Taylor MD.

JACC Cardiovasc Imaging. 2016 Mar;9(3):243-52. doi: 10.1016/j.jcmg.2015.05.013. Epub 2016 Feb 17. Review.

4.

The global burden of pulmonary hypertension in sickle cell disease: a systematic review and meta-analysis.

Musa BM, Galadanci NA, Coker M, Bussell S, Aliyu MH.

Ann Hematol. 2016 Oct;95(11):1757-64. doi: 10.1007/s00277-016-2693-z. Epub 2016 May 16. Review.

PMID:
27181705
5.

Pulmonary hypertension, tricuspid regurgitant velocity screening, and the nitric oxide pathway.

Hassell KL.

Hematology Am Soc Hematol Educ Program. 2011;2011:419-26. doi: 10.1182/asheducation-2011.1.419. Review.

PMID:
22160068
6.

Pulmonary hypertension in children with sickle cell disease.

Zuckerman WA, Rosenzweig EB.

Expert Rev Respir Med. 2011 Apr;5(2):233-43. doi: 10.1586/ers.11.6. Review.

PMID:
21510733
7.

Estimated pulmonary artery systolic pressure and sickle cell disease: a meta-analysis and systematic review.

Caughey MC, Poole C, Ataga KI, Hinderliter AL.

Br J Haematol. 2015 Aug;170(3):416-24. doi: 10.1111/bjh.13447. Epub 2015 Apr 9. Review.

PMID:
25854714
8.

Pulmonary hypertension in sickle cell disease: diagnosis and management.

Ataga KI, Klings ES.

Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):425-31. doi: 10.1182/asheducation-2014.1.425. Epub 2014 Nov 18. Review.

PMID:
25696889
9.

Pulmonary hypertension in sickle cell disease: relevance to children.

Kato GJ, Onyekwere OC, Gladwin MT.

Pediatr Hematol Oncol. 2007 Apr-May;24(3):159-70. Review.

10.

The relationship between "normal" transesophageal color-flow Doppler-defined tricuspid regurgitation and thermodilution right ventricular ejection fraction measurements.

Rafferty T, Durkin M, Hines RL, Elefteriades J, O'Connor TZ.

J Cardiothorac Vasc Anesth. 1993 Apr;7(2):167-74. Review.

PMID:
8477021
11.

Pulmonary hypertension in sickle cell disease.

Lee MT, Rosenzweig EB, Cairo MS.

Clin Adv Hematol Oncol. 2007 Aug;5(8):645-53, 585. Review.

PMID:
17982405
12.

Adenosine signaling in normal and sickle erythrocytes and beyond.

Zhang Y, Xia Y.

Microbes Infect. 2012 Aug;14(10):863-73. doi: 10.1016/j.micinf.2012.05.005. Epub 2012 May 23. Review.

Supplemental Content

Support Center